Mirae Asset Global ETFs Holdings’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-57,495
Closed -$884K 3137
2025
Q4
$884K Buy
57,495
+1,150
+2% +$12.7K ﹤0.01% 1591
2025
Q3
$557K Sell
56,345
-9,254
-14% -$96.3K ﹤0.01% 1821
2025
Q2
$651K Sell
65,599
-20,822
-24% -$219K ﹤0.01% 1669
2025
Q1
$1.13M Buy
86,421
+1,625
+2% +$21.5K ﹤0.01% 1440
2024
Q4
$1.08M Buy
84,796
+2,206
+3% +$26.7K ﹤0.01% 1502
2024
Q3
$919K Buy
82,590
+5,775
+8% +$63.7K ﹤0.01% 1588
2024
Q2
$864K Buy
+76,815
New +$894K ﹤0.01% 1534

Other funds holding DVAX

Mirae Asset Global ETFs Holdings's DVAX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 57,495 shares — an estimated $884K sold.

Mirae Asset Global ETFs Holdings first reported a position in DVAX in Q2 2024 and held it in 7 quarters. The position peaked at $1.13M in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 57,495 Dynavax Technologies shares in Q1 2026, an estimated $884K.
  • Mirae Asset Global ETFs Holdings first reported a position in Dynavax Technologies in Q2 2024 and held it in 7 quarters.
  • Mirae Asset Global ETFs Holdings's Dynavax Technologies position peaked at $1.13M in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.